BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37081760)

  • 1. Pure and mixed clear cell carcinoma of the endometrium: A molecular and immunohistochemical analysis study.
    Reijnen C; Vrede SW; Eijkelenboom A; Draak R; Sweegers S; Snijders MPLM; van Gestel P; Pijnenborg JMA; Bulten J; Küsters-Vandevelde HVN
    Cancer Med; 2023 Jun; 12(11):12365-12376. PubMed ID: 37081760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The Cancer Genome Atlas-like Prognostic Subgroups.
    Irshaid L; Costigan DC; Dong F; Matulonis UA; Nucci MR; Kolin DL
    Mod Pathol; 2023 May; 36(5):100123. PubMed ID: 36857998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear cell carcinoma of the endometrium: an immunohistochemical and molecular analysis of 45 cases.
    Zannoni GF; Santoro A; Angelico G; Spadola S; Arciuolo D; Valente M; Inzani F; Pettinato A; Vatrano S; Fanfani F; Scambia G; Fraggetta F
    Hum Pathol; 2019 Oct; 92():10-17. PubMed ID: 31269413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma With Clear Cell Change, and Clear Cell Carcinoma.
    Lim D; Ip PP; Cheung AN; Kiyokawa T; Oliva E
    Am J Surg Pathol; 2015 Aug; 39(8):1061-9. PubMed ID: 25871622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure compared with mixed serous endometrial carcinoma: two different entities?
    Roelofsen T; van Ham MA; Wiersma van Tilburg JM; Zomer SF; Bol M; Massuger LF; Bulten J
    Obstet Gynecol; 2012 Dec; 120(6):1371-81. PubMed ID: 23168762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of
    Beinse G; Rance B; Just PA; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Batteux F; Durdux C; Chapron C; Pasmant E; Leroy K; Alexandre J; Borghese B
    Int J Gynecol Cancer; 2020 May; 30(5):640-647. PubMed ID: 32169874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should endometrial clear cell carcinoma be classified as Type II endometrial carcinoma?
    Bae HS; Kim H; Young Kwon S; Kim KR; Song JY; Kim I
    Int J Gynecol Pathol; 2015 Jan; 34(1):74-84. PubMed ID: 25473756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of PD-L1 and its correlation with microsatellite status in endometrial and ovarian clear cell carcinomas: a cross-sectional study.
    Ghasemi D; Ameli F; Nili F; Edjtemaei R; Sheikhhasani S
    BMC Cancer; 2022 Dec; 22(1):1362. PubMed ID: 36581850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted mutation analysis of endometrial clear cell carcinoma.
    Hoang LN; McConechy MK; Meng B; McIntyre JB; Ewanowich C; Gilks CB; Huntsman DG; Köbel M; Lee CH
    Histopathology; 2015 Apr; 66(5):664-74. PubMed ID: 25308272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification.
    Kim SR; Cloutier BT; Leung S; Cochrane D; Britton H; Pina A; Storness-Bliss C; Farnell D; Huang L; Shum K; Lum A; Senz J; Lee CH; Gilks CB; Hoang L; McAlpine JN
    Gynecol Oncol; 2020 Jul; 158(1):3-11. PubMed ID: 32331700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution copy number analysis of clear cell endometrial carcinoma.
    O'Hara AJ; Le Gallo M; Rudd ML; Bell DW
    Cancer Genet; 2020 Jan; 240():5-14. PubMed ID: 31678638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases.
    Köbel M; Meng B; Hoang LN; Almadani N; Li X; Soslow RA; Gilks CB; Lee CH
    Am J Surg Pathol; 2016 Feb; 40(2):166-180. PubMed ID: 26492180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis.
    Travaglino A; Raffone A; Santoro A; Raimondo D; Angelico G; Valente M; Arciuolo D; Scaglione G; D'alessandris N; Casadio P; Inzani F; Mollo A; Seracchioli R; Zannoni GF
    Gynecol Oncol; 2021 Sep; 162(3):804-808. PubMed ID: 34266691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Molecular and Immunohistochemical Analyses of Endometrial Clear Cell Carcinoma Show that POLE Mutations and DNA Mismatch Repair Protein Deficiencies Are Uncommon.
    Baniak N; Fadare O; Köbel M; DeCoteau J; Parkash V; Hecht JL; Hanley KZ; Gwin K; Zheng W; Quick CM; Jarboe EA; Liang SX; Kinloch M
    Am J Surg Pathol; 2019 Apr; 43(4):531-537. PubMed ID: 30585826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent Mismatch Repair Protein Deficiency in Mixed Endometrioid and Clear Cell Carcinoma of the Endometrium.
    Köbel M; Tessier-Cloutier B; Leo J; Hoang LN; Gilks CB; Soslow RA; Delair D; Stewart CJR; Lee CH
    Int J Gynecol Pathol; 2017 Nov; 36(6):555-561. PubMed ID: 28114191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
    Fadare O; Parkash V
    Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
    Iwamoto M; Nakatani Y; Fugo K; Kishimoto T; Kiyokawa T
    Hum Pathol; 2015 Jul; 46(7):957-62. PubMed ID: 25971546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome Analysis of Ovarian and Uterine Clear Cell Malignancies.
    Alldredge J; Randall L; De Robles G; Agrawal A; Mercola D; Liu M; Randhawa P; Edwards R; McClelland M; Rahmatpanah F
    Front Oncol; 2020; 10():598579. PubMed ID: 33415077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
    Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in exons 6 and 7 of TP53 gene correlate positively with serum tumor necrosis factor alpha independent of microsatellite instability in BAT26 gene in Egyptian patients with endometrial carcinoma.
    Diab AM; Tawfeek TA; Moeity F; Elsammak M
    Int J Biol Markers; 2006; 21(3):184-9. PubMed ID: 17013801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.